Physician profile
Daniel C Fitzpatrick
NPI 1558361873
$480,846.30
in general payments reported to CMS, 2019-2025
13 companies · $59K in 2025
The $59K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89K · 2020: $83K · 2021: $57K · 2022: $63K · 2023: $69K · 2024: $61K · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $188K · Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $188,271.08 |
| Food and Beverage | $283.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $467,645.49 | 2019-2025 | Matrixrib |
| Zimmer Biomet Holdings, INC. | $12,828.40 | 2019-2024 | Rosa |
| Depuy Synthes Sales INC. | $121.18 | 2021 | |
| Stryker Corporation | $44.55 | 2019-2025 | Pangea |
| Orthopediatrics Corp. | $40.05 | 2025 | |
| Encore Medical, LP | $37.09 | 2024 | Djo Surgical |
| Medacta USA, INC. | $35.15 | 2025 | M-Vizion |
| Biocomposites INC | $27.18 | 2025 | Stimulan |
| Sonex Health, INC. | $18.70 | 2025 | Sx-One Microknife |
| Innovation Technologies INC | $18.53 | 2025 | Irrisept |
| Sanara Medtech INC. | $17.16 | 2025 | Celleraterx |
| Steelhead Surgical INC | $12.82 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fitzpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.